Heart disease remains one of the leading causes of death worldwide. For decades, aspirin has been widely used to help people with heart problems prevent heart attacks and strokes.
Aspirin works by thinning the blood so that clots are less likely to form and block blood flow to the heart or brain. This simple medicine has saved many lives and is still commonly recommended by doctors.
However, aspirin is not a perfect solution. While it helps prevent dangerous clots, it can also increase the risk of serious bleeding, especially in the stomach and brain. This side effect can sometimes be life-threatening. Because of these risks, scientists have been searching for safer and more effective medicines that can protect the heart without causing as much harm.
A new study from the Cardiocentro Ticino Foundation in Switzerland suggests that another type of drug may be a better choice for many patients. The research focused on medications called P2Y12 inhibitors.
These drugs are already used together with aspirin for a short time after a heart attack to prevent further problems. Examples include clopidogrel, prasugrel, and ticagrelor. Researchers wanted to know whether taking one of these drugs alone, instead of aspirin, could provide better long-term protection.
To find out, the scientists studied more than 24,000 people who had heart disease. The participants were divided into two groups. One group took aspirin, while the other group took a P2Y12 inhibitor. The researchers followed them for about a year and a half to see who experienced another heart attack, stroke, or serious bleeding.
The results were surprising and important. People taking P2Y12 inhibitors were less likely to have a heart attack or stroke compared with those taking aspirin. Overall, the risk of these major heart events dropped by about 12 percent.
The number of heart attacks alone fell by nearly one quarter in the group using the newer drugs. Even small improvements in prevention can save many lives, so these findings are significant.
One of the biggest concerns with blood-thinning medicines is bleeding. Unexpectedly, the study found that serious bleeding was not higher among people taking P2Y12 inhibitors. In fact, dangerous bleeding in the stomach or brain occurred less often compared with aspirin users. This suggests the newer drugs may offer stronger protection with fewer risks.
The study was led by Professor Marco Valgimigli and his research team. They believe these findings could change how doctors treat heart disease in the future. If further research confirms the results, P2Y12 inhibitors could become the preferred long-term treatment instead of aspirin for many patients.
Heart disease continues to threaten millions of lives, so improving prevention is extremely important. This research offers hope for safer treatment options that protect the heart more effectively. Still, treatment decisions should always be made with a doctor, since each patient’s situation is different.
The findings open the door to a new approach in heart care. Medicines that provide better protection while reducing dangerous side effects could help people live longer and healthier lives. As research continues, patients and doctors may soon have a smarter and safer alternative to the familiar aspirin.
If you care about heart health, please read studies about top 10 foods for a healthy heart, and how to eat right for heart rhythm disorders.
For more health information, please see recent studies about how to eat your way to cleaner arteries, and salt and heart health: does less really mean more?
Copyright © 2026 Knowridge Science Report. All rights reserved.
